Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Leukemia 10(10):1563-9, 1996
At its highest dose, 36 mg, participants in a phase 3 trial lost an average of 12.4 percent of their starting weight over 72 weeks
Eli Lilly, Zepbounds manufacturer, offers a similar deal
Cell 1997
SIRT2-dependent IDH1 deacetylation at K224 impairs its enzymatic activity and represses its malignant behaviors in CRC
In addition, Lilly has said it should be able to scale up production of orforglipron without the same supply constraints that it's faced with Mounjaro and Zepbound
US$ 26.22
US$ 24.07
US$ 21.76
US$ 23.76
US$ 29.50
US$ 21.80
